Last year, there were 1,015 biopharmaceutical deals recorded by Cortellis Deals Intelligence, with projected values at signing of $80.89 billion. This total represented a slight 3 percent drop on the deal totals calculated in 2016, and a 24 percent decline over 2015, despite the fact that the deal volume was 24 percent and 12 percent higher than the 2016 and 2015 volumes, respectively. Read More
Oral mucositis, painful sores that form in the mouths of many cancer patients, are more than just an annoying side effect of radiation and chemotherapy treatments. When they reach grade 3, patients can no longer eat solid foods, and at grade 4 patients can no longer even drink, often resulting in the stopping of cancer treatments. Read More